Skip to main content
OpenTrials

Clinical trial condition

Essential Thrombocythemia

Explore clinical trials studying Essential Thrombocythemia. Study availability and eligibility vary by location and protocol.

72 public trials 17 recruiting studies
Refine in advanced search Browse all conditions

Essential Thrombocythemia trial results

Active, not recruiting

Ropeginterferon Alfa-2b (P1101) vs. Anagrelide in Essential Thrombocythemia Patients With Hydroxyurea Resistance or Intolerance

NCT04285086

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +7 more
Locations
  • Mayo Clinic - Scottsdale Scottsdale, Arizona, United States
  • Washington University School of Medicine - Division of Oncology St Louis, Missouri, United States
  • MD Anderson Cancer Center Houston, Texas, United States
  • University of Utah Salt Lake City, Utah, United States
View all 67 locations
View Trial Details
Active, not recruiting

Topotecan Hydrochloride and Carboplatin With or Without Veliparib in Treating Advanced Myeloproliferative Disorders and Acute Myeloid Leukemia or Chronic Myelomonocytic Leukemia

NCT03289910

Conditions
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Atypical Chronic Myeloid Leukemia, +32 more
Locations
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • USC Norris Oncology/Hematology-Newport Beach Newport Beach, California, United States
  • Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
View Trial Details
Active, not recruiting

A Single-arm, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of P1101 in Adults With ET

NCT05482971

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +8 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • City of Hope National Medical Center Duarte, California, United States
  • Marin Cancer Care Greenbrae, California, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
View all 34 locations
View Trial Details
Completed

Myeloproliferative Neoplasms: an In-depth Case-control Study

NCT01831635

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +13 more
Locations
  • University Hospitals Southampton NHS Foundation Trust Southampton, England, United Kingdom
  • Belfast Health And Social Care Trust Belfast, Northern Ireland, United Kingdom
  • Queen's University Belfast Belfast, Northern Ireland, United Kingdom
View Trial Details
Completed

Study of Bomedemstat in Participants With Essential Thrombocythemia (IMG-7289-CTP-201/MK-3543-003)

NCT04254978

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +7 more
Locations
  • Local Institution Jacksonville, Florida, United States
  • Local Institution Ann Arbor, Michigan, United States
  • Local Institution New York, United States
  • Local Institution Durham, North Carolina, United States
View all 26 locations
View Trial Details
Completed

Veliparib and Topotecan With or Without Carboplatin in Treating Patients With Relapsed or Refractory Acute Leukemia, High-Risk Myelodysplasia, or Aggressive Myeloproliferative Disorders

NCT00588991

Conditions
Adult Acute Megakaryoblastic Leukemia, Adult Acute Monoblastic Leukemia, Adult Acute Monocytic Leukemia, +55 more
Locations
  • Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
  • Mayo Clinic in Rochester Rochester, Minnesota, United States
View Trial Details

Related conditions